
- BioPharm International-04-01-2015
- Volume 28
- Issue 4
IV Bag Filling and Closing System Eliminates Contamination
Bausch’s second generation Type 529 is a semi-automatic IV bag filling and closing machine designed for aseptic packaging of infusions, parenteral drugs, and other fluids with a fully integrated automatic closing system to eliminate possible contamination.
Bausch’s second generation Type 529 is a semi-automatic IV bag filling and closing machine designed for aseptic packaging of infusions, parenteral drugs, and other fluids with a fully integrated automatic closing system to eliminate possible contamination. The system handles IV bags from 10 mL-10 L, with the ability to produce up to 1600 aseptic bags in one hour, and the updated design is suited for isolator or closed restricted access barrier systems applications because it eliminates obstruction of the laminar air flow into the open bag.
Up to four filling and closing stations can be added to the system using the original electronics, industrial personal computer, and human machine interface to expand versatility and allow for production growth. Dosing technology options for the system include mass flow, peristaltic pump, servo-operated pinched valve, and rotary piston pumps, all with the option of process control technology. Other options include hard port or flexible tubing closures; high frequency, ultrasonic, or heat sealing technologies; and air evacuating and pre- and/or post-gassing system and can be integrated with clean-in-place or sterilize-in-place systems.
Articles in this issue
over 10 years ago
Modern Manufacturing Systems Key to FDA Quality Initiativeover 10 years ago
Advanced Liquid Particle Counters to Measure Aggregated Proteinsover 10 years ago
Novel Drug Delivery through Use of a Foamed Excipientover 10 years ago
Formulating for Needle-free Jet Injectionover 10 years ago
More Evidence that Size Mattersover 10 years ago
Drug Discovery and Development in Indiaover 10 years ago
Core-Shell Phase Column Increases ReproducibilityNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.